![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 28, 26479-26485, July 13, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, March 26, 2001, and in revised form, May 2, 2001
An antigenic similarity between lipopolysaccharide
(LPS) and glycosylated pilin of Pseudomonas aeruginosa 1244 was noted. We purified a glycan-containing molecule from
proteolytically digested pili and showed it to be composed of three
sugars and serine. This glycan competed with pure pili and LPS for
reaction with an LPS-specific monoclonal antibody, which also inhibited twitching motility by P. aeruginosa bearing glycosylated
pili. One-dimensional NMR analysis of the glycan indicated the
sugars to be 5N Pseudomonas aeruginosa is an opportunistic pathogen
capable of causing severe infections in individuals with compromised
defense mechanisms (1). The somatic pili, protein filaments that extend as bundles from one or both of the cell poles, are considered to be a
major virulence factor, promoting adherence and invasiveness (2, 3).
These fibers are composed of a monomeric subunit, pilin, which has a
strain-dependent molecular weight of ~16,000. The mature
form of this protein is produced by the removal of a six-residue leader
sequence, a process that is accompanied by methylation of the nascent
amino-terminal phenylalanine (4). Although this had initially been
considered the only post-translational modification of this protein,
evidence has been generated indicating that P. aeruginosa
strain 1244 pilin is also glycosylated (5). This process is dependent
on pilO, a gene present as part of an operon that also
contains the pilin structural gene, pilA.
Although archeal and eubacterial S-layers commonly contain covalently
bound glycan (6-8), other examples of glycosylated prokaryotic surface
proteins are rare. Cell wall-associated glycoproteins have been
demonstrated in Streptococcus sanguis (9) and
Mycobacterium tuberculosis (10). Among Gram-negative
bacteria, Campylobacter species have been shown to contain a
general protein glycosylation system that modifies a number of surface
proteins including flagellin (11-13). Evidence has been presented that
a glycan is associated with P. aeruginosa flagellin (14). As
with P. aeruginosa (5), the pili of Neisseria
meningitidis and Neisseria gonorrhoeae have been shown
to be glycosylated. X-ray diffraction studies indicate that the
N. gonorrhoeae pilin glycan is a disaccharide (15). In
addition to glycerol phosphate (16), N. meningitidis pilin contains covalently bound trisaccharide (17).
Although the detection of glycosylated bacterial surface proteins is
uncommon, the comprehensive determination of their carbohydrate structure has been even more rare. Results presented in this paper provide a complete structural analysis of the P. aeruginosa 1244 pilin glycan, showing that it is a
serine-linked trisaccharide with the following structure:
Bacterial Strains--
P. aeruginosa strain 1244, a
smooth human blood isolate of LPS serotype O7, was originally provided
by A. T. McManus, U. S. Army Institute of Surgical Research, San
Antonio, and strain 1244N3 was provided by S. Lory, University of
Washington, Seattle. P. aeruginosa strain 653A was from
C. C. Brinton, University of Pittsburgh. All strains were grown
aerobically on LB plates or broth cultures at 37 °C. Broth cultures
were grown on a rotatory shaker at 275 rpm. Additions to the
growth media were as follows: carbenicillin, 200 µg/ml; tetracycline,
50 µg/ml; isopropyl- Immunological Procedures--
Western blotting was performed as
described previously (19). The mAbs used were a gift from J. C.
Sadoff, Walter Reed Army Institute of Research, Washington, D. C. mAb
1.2.48 was a hybridoma supernatant fluid, and mAbs 11.14 and 5.44 were
ascites fluids. When used in Western blots or twitching inhibition
tests, mAbs 11.14 and 5.44 were purified as follows. Ammonium sulfate
(0.67 g) was added to 2.0 ml of ascites fluid followed by stirring for 30 min at 4 °C. This material was centrifuged at 12,000 × g for 15 min at room temperature, and the supernatant fluid
was discarded. The precipitate was dissolved in 1.0 ml of 10.0 mM Tris/HCl, pH 8.0, and dialyzed three times against one
liter of the same buffer at 4 °C. These preparations were applied to
a 0.5 × 5.0-cm Mono-Q column equilibrated with this same buffer
and eluted with a 0.0-0.4 M NaCl gradient, again in the
same buffer, over a volume of 10.0 ml. Eluted protein was monitored by
absorption at 280 nm. Fractions (0.25 ml) were taken at a flow rate of
1.0 ml/min and assayed by SDS-polyacrylamide gel electrophoresis using
Coomassie Brilliant Blue G-250 stain. The P. aeruginosa 1244 LPS standard was a gift from from Dr. A. Bhattacharjee, Walter Reed
Army Institute of Research. Crude P. aeruginosa 653A LPS was
prepared using the procedure of Hitchcock and Brown (20).
Blocking enzyme-linked immunosorbent assay employed polystyrene plates
coated with either 50 µl of purified native 1244 pili (20 µg/ml) or
50 µl of purified strain 1244 LPS (10 µg/ml). Plates to be coated
with LPS as antigen were precoated with 50 µl of polylysine (1 mg/ml). All plates were blocked (2 h at room temperature) with 200 µl
of 0.5% casein and 0.5% bovine serum albumin in phosphate-buffered saline. Antibody preparations were diluted 3 × 10 Twitching Motility--
The motility assay described by
McMichael (21) was carried out as follows. Filter-sterilized
antibiotics, isopropyl- Preparation of Glycosylated and Nonglycosylated Pili--
Strain
1244N3, a mutant that is unable to make pilin (22), could produce
nonglycosylated strain 1244 pilin when carrying pPAC24, a plasmid
containing the strain 1244 pilA gene (which codes for pilin)
but lacking the pilO gene required for glycosylation. This
strain was able to produce glycosylated pilin when carrying pPAC46, a
plasmid containing both the strain 1244 pilA and
pilO genes (5). Glycosylated and nonglycosylated pili,
produced by hyperexpression of the pilA gene of pPAC46 and
pPAC24, respectively, were isolated and purified as described
previously (5). For use in Western blots, glycosylated and
nonglycosylated pilin were purified further to remove traces of LPS.
Here, pilin samples were incubated at room temperature for 15 min in
10.0 mM Tris/HCl, 1% (w/v) Isolation of Pilin Aminoglycan--
In a typical preparation,
~12.5 mg of pure glycosylated pili were suspended in 12 ml of a
solution containing 5 mM Tris/HCl, 0.5 mM
CaCl2, pH 7.6. To this was added 7.2 mg each of proteinase K and Pronase followed by 40 µl of toluene to suppress microbial growth. This material was incubated at 45 °C for ~18 h, at which time 1.8 mg each of proteinase K and Pronase were added. This was
incubated for an additional 18 h at 55 °C and dried in a stream of filtered air at 45 °C. The digested material was resuspended with
1.0 ml of deionized water, and after removal of precipitate by
centrifugation, it was passed through a 1.3 × 20-cm Sephadex G-25
column (calibrated with glucose and lactose) using 25 mM ammonium acetate, pH 8.5, as elution buffer. 0.5-ml fractions at a flow
rate of 0.35 ml/min were taken, and protein absorbance was monitored at
280 nm. Aliquots of fractions were incubated with 3.2% orcinol in 80%
sulfuric acid at 80 °C for 15 min, and the absorbance at 420 nm was
measured. The single peak that appeared in the 400-800 molecular
weight range was pooled and dried. Pili in the absence of protease, or
protease in the absence of pilin, produced no peak after similar
treatment. This dried material was dissolved in a minimal volume of
deionized water, loaded onto a 20 × 20-cm Whatman PE SIL G
polyester-backed silica gel plate (Fisher), and subjected to TLC using
an isopropanol-ammonium hydroxide (2:1) solvent (23).
The position of the glycan-containing band was determined by excising a
section of the plate and spraying it with an 0.11% orcinol in 0.3%
sulfuric acid solution followed by incubation at 90 °C for 60 min.
The area of the plate matching the orcinol-reactive band was scraped
and the glycan eluted with deionized water. This material was dried and
subjected to a second round of TLC using chloroform-methanol-water
(10:10:3; (24)) as solvent. Glycan from this plate was again subjected
to TLC using the isopropanol-ammonium hydroxide solvent. The purity of
the material resulting from this scheme was tested by two-dimensional
high performance TLC using Whatman silica gel glass-backed
plates (Fisher) and employing butanol-acetic acid-water (3:1:1) and
choroform-methanol-water (10:10:3) as solvents. Development of these
plates with either orcinol or ninhydrin (0.3% ninhydrin in 95%
ethanol followed by 90 °C treatment for 30 min) sprays produced a
single spot at identical Rf coordinates, indicating
that this material was of high purity and contained both a sugar moiety
and a free amino group. Approximately 450 µg of this material, as
determined by spot test using serine as standard, was obtained using
this procedure.
Amino Acid and Sugar Analysis--
The amino acid composition of
the isolated pilin aminoglycan was determined after hydrolysis in 1 M trifluoroacetic acid for 4 h at 95 °C. Hydrolysis
products were subjected to high performance TLC using the
isopropanol-ammonium hydroxide solvent described above with
L-serine, L-threonine, and
L-aspartic acid as standards and ninhydrin treatment for
detection. For confirmation, an aminoglycan sample was hydrolyzed
in vacuo in pre-pyrolyzed 10-mm tubes with 6 N
HCl, 0.5% phenol, at 110 °C for 24 h. Amino acid composition of vacuum-dried hydrolysates was carried out at the University of
Pittsburgh Protein Sequencing Facility using a Beckman 6300 amino acid
analyzer employing post-column ninhydrin detection. The sugar
composition of the isolated pilin aminoglycan was analyzed after
hydrolysis in 1 M HCl for 2-6 h at 95 °C. Hydrolysis
products were subjected to high performance TLC using glucose, lactose, and xylose as standards with acetone-water (9:1 (25)) as solvent and
orcinol spray for detection.
Mass Spectrometry--
Mass determination of glycosylated pilin
was performed at the Mellon Institute Center for Molecular Analysis,
Carnegie Mellon University, using a PerSeptive Biosystems Voyager
STR with delayed extraction and a high m/z
detector. Sequence and mass analysis of the pilin aminoglycan was
carried out by ESI-MS using a SCIEX API-III mass analyzer operated in
the positive ion mode with an orifice potential of 50 V. Spectra are
the accumulation of 10-15 scans collected over the mass range of 400 to 2,000. The sample was dissolved in distilled water at a final
concentration of 2 µg/µl, and the sample solution was mixed with an
equal volume of ESI-MS solution (aqueous 30% methanol containing 1%
hydrochloric acid) and pumped into the mass spectrometer at a rate of 3 µl/min. MS/MS was also performed on the SCIEX instrument by
selecting the parent ion for collision-induced dissociation using argon as the collision gas.
Nuclear Magnetic Resonance--
For NMR analysis, the dried
sample was dissolved in D2O and lyophilized. This procedure
was repeated, and then the sample was dissolved in 0.5 ml of
D2O and subjected to both one- and two-dimensional NMR
analyses. The spectra were acquired using a Varian 300 MHz instrument.
The gradient COSY, TOCSY, and ROESY experiments were performed using
the pulse sequences provided by Varian, and processed using Varian
software. Chemical shifts ( Xylose Linkage Analysis--
The xylosyl linkage was determined
by the preparation and GLC-MS analysis of its partially methylated
alditol acetate (PMAA). The PMAAs were prepared using the Hakomori
method as described by York et al. (26). Analysis of the
PMAAs was performed by GLC-MS on a Hewlett-Packard 5970 MSD using a
30-m SP2330 capillary column from Supelco (Bellefonte, PA).
Immunological Relationship between Pilin and LPS of P. aeruginosa 1244--
Previous work (27) has suggested that the pilin
and LPS of P. aeruginosa 1244 were immunologically similar.
To verify this, glycosylated 1244 pilin was analyzed by Western
blot using a mAb 11.14, which is specific for 1244 LPS O-antigen (28).
Fig. 1 shows that this antibody reacted with
pilin to produce a single band at the anticipated position and also
recognized LPS, as indicated by the typical ladder structure produced.
To determine whether this mAb was directed against the pilin glycan,
the nonglycosylated form of strain 1244 pilin (5) was also tested. Fig.
1 shows that whereas this antibody reacted with glycosylated pilin
there was no recognition of the nonglycosylated form, indicating that the pilin glycan was the reactive epitope. Anti-pilus mAb 5.44, previously shown to react with a peptide epitope (29), reacted with
both glycosylated and nonglycosylated pilin. Neither form of pilin nor
strain 1244 LPS reacted in the absence of primary antibody or in the
presence of a mAb directed against O6 serotype P. aeruginosa
LPS. Western blot analysis of the cytoplasmic, membrane, and
periplasmic cell fractions of strain 1244 showed that pilin and LPS
were the only antigens present that reacted with mAb
11.14.2 A polyclonal typing serum
directed against the LPS O antigen and specific for International
Antigenic Typing System serotype O7 (30) was found also to
recognize glycosylated but not nonglycosylated pilin, as determined by
Western blot (results not shown).
An antibody inhibition test was carried out to determine whether the
antigen detected by Western blot was present on native functional pili.
The pili of P. aeruginosa mediate a form of cell motility
called twitching (31) that can be inhibited by anti-pilus sera. If the
glycan epitope exists on the pilus surface and is accessible to
antibody reaction, inhibition of twitching motility by mAb 11.14 would
be expected. Table I shows that purified
mAb 11.14 inhibited twitching at concentrations as low as 1.6 µg/ml. Because this antibody also reacted with LPS, the possibility existed that twitching motility was inhibited through interaction with and not
by directly binding to the pili. To determine whether this was the
case, twitching inhibition was tested under conditions where only
nonglycosylated pili were produced. P. aeruginosa 1244N3, a
pilin-negative mutant (22) can produce glycosylated pili when carrying
pPAC46, a plasmid bearing the whole pilAO operon (5). This
organism carrying pPAC24, a plasmid containing PilA but not pilO, produced only nonglycosylated pilin. Table
II shows that twitching motility by the
strain producing glycosylated pili was sensitive to inhibition by mAb
11.14, whereas the strain producing nonglycosylated pili was not
affected. These results indicate that the 11.14-reactive epitope is
present on the surface of the pilus under physiological conditions.
Isolation and Preliminary Characterization of Pilin
Aminoglycan--
Initial experiments were carried out to confirm
the finding (5) that P. aeruginosa 1244 pilin was
post-translationally modified. Although the sequence of the pilin
structural gene, pilA, predicted a molecular weight of
15,648 for mature pilin, polyacrylamide gel electrophoresis suggested
that the value was ~16,900 (5). In the present study, MALDI analysis
of pure strain 1244 pilin produced a value of 16,307 (±25) (results
not shown), indicating the presence of covalently bound material with a
total mass of ~660 and with no signal seen at the mass predicted by the pilin gene. The use of a saccharide-specific probe indicated that
this pilin contained bound glycan (5). In the work presented here,
proteolytically digested pure pili were found to contain a glycan
material as determined by TLC using orcinol reagent detection. No
glycan was seen under the same digestion conditions in the absence of
either pili or protease.
The orcinol-reactive material released by pilus degradation was
purified by gel filtration and TLC and was found to be homogeneous as
determined by two-dimensional high performance TLC using either orcinol
or ninhydrin detection. The Rf coordinates of the
spots produced by these methods were identical. For preliminary identification of the amino-containing component, purified pilin aminoglycan was hydrolyzed (1 M trifluoroacetic acid for
4 h at 95C°) and the hydrolysate subjected to high performance
TLC, with undigested aminoglycan, serine, threonine, and aspartic acid
as references. The only ninhydrin-reactive spot present in the digested glycan matched the Rf of serine, which was absent in undigested aminoglycan (results not shown). These findings were confirmed by amino acid analysis where serine was the sole amino acid
present above background. Here it was found that 18.6 nmol of serine
(2.0 µg) was produced from 18.8 µg (as determined by sugar
analysis) of aminoglycan.
The aminoglycan was treated with 1 M HCl for 6 h at
95 C°, and the hydrolysate was subjected to high performance TLC
with orcinol detection. This procedure revealed the presence of three sugars, one of which corresponded in mobility to xylose (results not
shown). Gel filtration of the aminoglycan using a calibrated Sephadex
G-25 column indicated a molecular weight in the range of 400 to 800 (results not shown), which would be consistent with the additional mass
revealed by the MALDI analysis described above. Altogether, these
results suggest that the P. aeruginosa 1244 pilin monomer
has a single covalently bound trisaccharide O-linked to one
of the protein's 13 serine residues.
To determine whether the purified aminoglycan carried the mAb
11.14-specific epitope, blocking enzyme-linked immunosorbent assays
were carried out in which this molecule was allowed to compete with
pure native pili for antibody recognition. Fig.
2 shows that the aminoglycan efficiently
inhibited pili binding by mAb 11.14 but failed to interfere with mAb
5.44, which recognizes a pilin protein epitope (29). Competition was
also seen between the isolated glycan and pure strain 1244 LPS,
supporting the contention that the pilin glycan and strain 1244 LPS
O-antigen share a common epitope.
Structural Analysis of Pilin Aminoglycan--
Results presented
above suggested that P. aeruginosa 1244 pilin glycan was
antigenically related to the LPS O-antigen of this organism and was
structurally similar to an O-antigen repeating unit. Agglutination
testing using International Antigenic Typing System sera (results not
shown) showed that P. aeruginosa 1244 belonged to O-antigen
group O7, a serogroup that is equivalent to Lanyi-Bergan 7a,7b, 7c (30,
32). The O-antigen structure of a P. aeruginosa strain from
this serogroup has been determined (18, 33). These results provided
useful reference information for the structural analysis of the
P. aeruginosa 1244 pilin aminoglycan.
The proton spectrum of the pilin aminoglycan is shown in Fig.
3. The spectrum is consistent with this
oligosaccharide having three of the glycosyl residues reported for the
O-antigen polysaccharide from the LPS of P. aeruginosa (33),
namely, Xyl, FucNAc, and 5N
Proton assignments of this oligosaccharide
were made by COSY (Fig. 4) and TOCSY (Fig. 5)
NMR experiments. These assignments are shown in Table
III. The
The sequence of the glycosyl residues in the pilin oligosaccharide was
determined by a ROESY NMR spectrum, tandem MS/MS analysis, and
methylation analysis. The ROESY spectrum (Fig. 5) shows that H1 of Xyl
( Results presented in this report have shown that the P. aeruginosa 1244 pilin glycan is an O-linked
trisaccharide covalently attached through the Although the glycans of previously described bacterial glycoproteins
did not show similarities with common cell saccharides, the P. aeruginosa 1244 pilin glycan revealed a structure that has the
same sugar composition and sequence as the O-antigen repeating unit of
P. aeruginosa 170046, a strain belonging to the LPS O7 serotype (33). The pilin glycan differs from the O-antigen only in that
the FucNAc residue is not O-acetylated. The structural similarity between the P. aeruginosa 1244 pilin glycan and
the O7 repeating unit suggests a common biosynthetic origin in which pilin glycosylation might occur as a branch of the pathway of O-antigen
production. If this is the case, candidate pilin glycosylation substrates could be nucleotide-sugar intermediates of O-antigen biosynthesis or the complete repeating unit borne on bactoprenyl pyrophosphate (35), a molecule normally anchored on either the inner or
outer surfaces of the cytoplasmic membrane. This would be a process
similar to the dolichol path of protein glycosylation present in yeasts
and archeabacteria (6, 36). PilO, which is required for pilin
glycosylation (5), is predicted to be a membrane protein that, if
located in the cytoplasmic membrane, would be situated correctly for
modification of the membrane bound pilin (either following pilin
biosynthesis or after transport to the periplasm). If the pilin glycan
is produced in this manner, the O-antigen structure should be identical
with that of the glycan. Structural analysis of the strain 1244 O-antigen is currently under way to determine this point.
The wall-associated glycan of S. sanguis, (9) as well as
certain S-layer and flagellin glycans of Halobacterium
halobium (6-8), are N-linked to the amido nitrogen of
an asparagine residue. The S-layer protein glycan of
Thermoanaerobacter thermohydrosufuricus is
O-linked to a tyrosine residue (37), whereas the M. tuberculosis wall glycan is O-linked through a
threonine residue (10). By contrast the pilin glycans of N. meningitidis and N. gonorrhoeae, like that of P. aeruginosa 1244, are all O-linked to serine residues (15-17). Although the trisaccharide structure of N. meningitidis and the disaccharide of N. gonorrhoeae are
both attached at pilin serine 63 (15, 17) and the N. meningitidis glycerophosphate is covalently bound at serine
93 (16), the site of the P. aeruginosa 1244 pilin glycan has
not yet been elucidated. Strain 1244 pilin does not share homology with
the neisserial proteins in these regions, nor does it have serine
residues in the same relative positions.
The strain 1244 pilin belongs to a homogeneous subtype that is commonly
found among P. aeruginosa clinical isolates (29). Although
these findings suggest that this modification is widespread, it is
clear that it is not universal because P. aeruginosa strains PAO and PAK produce only nonglycosylated pili (38, 39). The role of
pilin glycosylation, particularly as to whether or not it offers a
selective advantage with regard to virulence, remains to be determined.
It has been proposed that glycosylation of N. meningitidis
pilin influences adhesion (40). Marceau et al. (41) produced
evidence that this was not the case, but they showed that pilin
glycosylation was associated with the production of S-pilin, a
truncated form of this protein. Antibody attachment to the pilus glycan
of N. meningitidis has been shown to prevent complement
binding (42), a response that could protect against phagocytosis.
5N Because the pilin glycan exists on the fiber surface, as demonstrated
by its accessibility to antibody binding under physiological conditions, it has the potential for having a significant effect on the
relation of the pilus with its chemical and physical environment. However, for this to be the case, the glycan must be uniformly accessible to the pilus fiber surface. For example, if the glycan exists complexed with the pilin subunits in such a way that is partially buried, a situation analogous to the P. aeruginosa pilin disulfide loop adhesion site that is a part of
each subunit but is available for antibody binding only at the pilus
tip (44), it would have limited influence. However, if the glycan
extends evenly from the pilus surface, it would be expected to increase the solubility of the pilus fibers by modulating the inherent hydrophobicity (45) of this structure. In addition, the presence of
5N We thank J.C. Sadoff for valuable discussions
and suggestions.
*
This work was supported by NIAID, National Institutes of
Health, Grant R15 AI43317, United States Army Grant DAAL03-88-G-0103, and Department of Energy Grant DE-FG02-93ER20097 to the Complex Carbohydrate Research Center at the University of Georgia.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed. Tel: 412-396-6319; Fax:
412-396-5907; E-mail: castric@duq.edu.
Published, JBC Papers in Press, May 7, 2001, DOI 10.1074/jbc.M102685200
2
J. Rao and P. Castric, unpublished observations.
The abbreviations used are:
LPS
lipopolysaccharide, COSY, 1H-1H correlated NMR
spectroscopy;
ESI-MS, electrospray ionization mass spectrometry;
FucNAc, N-acetylfucosamine;
GLC-MS, gas-liquid
chromatography-electron impact mass spectrometry;
LB, Luria-Bertani;
mAb, monoclonal antibody;
MALDI, matrix-assisted laser
desorption/ionization;
MS/MS, tandem mass spectrometry;
PMAA, partially methylated alditol acetate;
5N
Structural Characterization of the Pseudomonas
aeruginosa 1244 Pilin Glycan*
§,
Department of Biological Sciences, Duquesne
University, Pittsburgh, Pennsylvania 15282, the ¶ Department
of Enteric Infections, Walter Reed Army Institute of Research,
Washington, D. C. 20307, and the
Complex Carbohydrate
Research Center, University of Georgia, Athens, Georgia 30602
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
OHC47NfmPse, Xyl, and FucNAc. The
complete proton assignments of these sugars as well as the serine
residue were determined by COSY and TOCSY. Electrospray ionization mass
spectrometry (MS) determined the mass of this molecule to be 771.5. The
ROESY NMR spectrum, tandem MS/MS analysis, and methylation
analysis provided information on linkage and the sequence of
oligosaccharide components. These data indicated that the molecule had
the following structure:
-5N
OHC47NFmPse-(2
4)
-Xyl-(1
3)-
-FucNAc-(1
3)-
-Ser.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-5N
OHC47NFmPse-(2
4)-
-Xyl-(1
3)-
-FucNAc-(1
3)-Ser. 5N
OHC47NFmPse is an infrequently occurring sugar found
in certain P. aeruginosa O-antigens (18). All three
pilin glycan sugars are repeating unit components of O7
LPS,1 the serotype to which
P. aeruginosa 1244 belongs (18).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-D-thiogalactopyranoside, 5.0 mM.
4 with blocker and incubated for 2 h
at room temperature with purified pilin aminoglycan. This material (50 µl) was added to the coated plates and incubated overnight at room
temperature with slow shaking. Secondary antibody (50 µl of alkaline
phosphatase-labeled goat anti-mouse immunoglobulin G (heavy and
light chains), 1:1000 dilution, Kirkegaard and Perry Laboratories,
Inc., Gaithersburg, MD) was applied for 2 h at room temperature
with slow shaking. Each step was followed by four washes with
phosphate-buffered saline. Plates were assayed by the addition of
substrate (150 µl of 10% diethanolamine, 0.05%
p-nitrophenylphosphate (Sigma), 0.5 mM
MgCl2, pH 9.8) followed by incubation at room temperature
with shaking from 10 to 30 min. The reaction was stopped with the
addition of 50 µl of 0.1 M ethylenediaminetetracetic acid, and the A405 was measured using a Bio-Rad
model 3550 plate reader.
-D-thiogalactopyranoside, or
monoclonal antibody were added to 3.3 ml of melted LB agar (containing
1% agar), which was poured into a 15 × 60-mm plastic Petri dish.
After solidification, the plate was dried, with lid side up, at
37 °C for 6 h. The medium was then stab-inoculated with the
test organism so that the inoculating needle came in contact with the
bottom of the plate. The diameter of the zone of growth that radiated
from the inoculation point between the agar layer and the interior
bottom of the plate was measured after an 18-h incubation at
37 °C.
-octyl glucoside, pH 8.0, for 20 min. These proteins were next subjected to gel filtration using
a 1.0 × 30.0-cm Superose-12 column equilibrated with 10.0 mM Tris/HCl and 1.0%
-octyl glucoside at pH 8.0. Fractions (0.5 ml) were collected at a flow rate of 0.5 ml/min.
Glycosylated pilin from this step was applied to an 0.5 × 10.0-cm
Mono-P column equilibrated with 0.025 M
2-[Bis(2-hydroxyethyl)imino]-2-(hydroxymethyl)-1,3-propanediol, adjusted to pH 6.25 with HCl, and eluted with 10.0 ml of a solution containing 10% (w/v) Polybuffer 74 (Amersham Pharmacia Biotech) and
1% (w/v)
-octyl glucoside, pH 4.0. Nonglycosylated pilin was
applied to a Mono-P column equilibrated with 0.025 M
triethanolamine equilibrated to pH 8.3 with acetic acid and eluted with
10.0 ml of a solution containing 0.2% (w/v) Pharmalyte 8-10.5
(Amersham Pharmacia Biotech), 9% (w/v) Polybuffer 96 (Amersham
Pharmacia Biotech), 1% (w/v)
-octyl glucoside, pH 6.0. Fractions
(0.5 ml) were taken at a flow rate of 1.0 ml/min. Protein elution was
monitored by absorption at 280 nm. Glycosylated pilin eluted at
approximately pH 4.8, whereas nonglycosylated pilin eluted at pH 6.8. These proteins were dialyzed against 10 mM Tris/HCl, pH
8.0, and stored frozen. No LPS was detected as determined by Western
blot using an anti-LPS-specific serum.
) are expressed in parts per million
downfield from internal trimethylsilylpropionate with an accuracy of
0.002 ppm.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (78K):
[in a new window]
Fig. 1.
Western blot of glycosylated and
nonglycosylated P. aeruginosa 1244 pilin. Lanes
1, 4, 6, and 9 each contained ~0.5 µg of
glycosylated pilin/lane. Lanes 2, 5, 7, and
10 each contained ~0.6 µg of nonglycosylated pilin/lane.
Lanes 3, 8, and 11 each contained
~1.5 µg of purified P. aeruginosa 1244 LPS (serotype
O7). Lane 12 contained 10 µl of a crude P. aeruginosa 653A LPS (serotype O6) preparation. Lanes
1-3 were probed with O7-specific mAbl 11.14. Lanes 4 and 5 were probed with pilin
protein-specific monoclonal 5.44. Lanes 6-8 were not
treated with primary antibody. Lanes 9-12 were probed with
O6-specific mAb 1.2.48. The arrows indicate the
position of molecular size standards, with values shown in kDa.
Inhibition of P. aeruginosa 1244 twitching motility by a
glycan-specific mAb
Pilin glycan-specific inhibition of twitching motility in P. aeruginosa 1244N3

View larger version (20K):
[in a new window]
Fig. 2.
Blocking enzyme-linked immunosorbent assay
using purified P. aeruginosa 1244 pilin glycan.
Wells were coated with P. aeruginosa pili
(triangles and circles) or LPS
(squares). The test antibody was mAb 11.14 (triangles and squares), and the control was mAb
5.44 (circles). The molar concentration of the inhibitor was
approximated using the mass difference between glycosylated and
nonglycosylated pilin. This procedure is described under
"Experimental Procedures."
OHC47NFmPse. Consistent with
the previous report (33), the anomeric resonance at
4.54 (J1, 2 8.0 Hz) was assigned to FucNAc and that at
4.43 (J1, 2 7.6 Hz) to Xyl. Both of these glycosyl
residues are
-linked. In addition, the 7.6 Hz J1,2
coupling of Xyl shows that it is in the pyranose, and not the furanose,
form because a
-furanosyl conformation would have a J1.2
coupling of less than 1 Hz (34). The resonances at
1.52 (J3a, 3e = 13.3 Hz) and
2.14 (J3a, 3e = 13.3 Hz; J3a, 4 = 4.6 Hz) are consistent with the
previously reported axial and equatorial protons, respectively,
of 5N
OHC47NFmPse. In agreement with knirel et
al. (33), the chemical shift difference between H3a and H3e of
0.62 shows that the 5N
OHC47NFmPse is
-linked. The
resonance at
2.06 is due to the methyl protons of the
N-acetyl group of FucNAc. A resonance corresponding to the
methyl group of an O-acetyl group is not observed indicating
that this oligosaccharide is not O-acetylated. The
resonances from
1.23 to
1.32 are due to the H6
methyl protons of FucNAc, the H9 methyl protons of
Pse5N
OHC47NFm, and the H4 methyl protons of a
-hydroxybutyryl group. The resonance at
8.09 is due to the
proton of the N-formyl group at position 7 of
Pse5N
OHC47NFm. The resonances centered around
2.45 are consistent with the H2 protons of the
N-
-hydroxybutyryl substituent of
5N
OHC47NFmPse.

View larger version (19K):
[in a new window]
Fig. 3.
A proton spectrum of the pilin
oligosaccharide.
-Xyl resonances for the pilin
oligosaccharide also vary from those reported for the O-antigen
polysaccharide (33). It is likely that this variation is due to the
fact that, in the latter case, all of the O-antigen derived
oligosaccharides contained Xyl as a terminally linked residue, whereas
it is 4-linked in the pilin oligosaccharide (discussed further below).
The resonances of the FucNAc are consistent with the lack of an
O-acetyl substituent. O-Acetylation of the FucNAc
residue at O-4 would have resulted in an H4 chemical shift position of
approximately
5.2 as reported by Knirel et al. (33).
However, the FucNAc H4 in the pilin aminoglycan has a chemical shift at
3.92. In addition to these differences in the glycosyl residue
protons, two other protons (
4.10 and
3.93) were observed that
were coupled to one another but not to any of the other protons in this
molecule. These protons are consistent with those of serine, the only
amino acid component of this oligosaccharide (discussed above). Thus,
the NMR results indicate that this molecule consists of FucNAc,
5N
OHC47NFmPse, Xyl, and Ser. The calculated molecular
weight for such a molecule is 770, a value that is supported by the
mass spectrometric data, which give an [M+H]+ of
m/z 771.5.

View larger version (43K):
[in a new window]
Fig. 4.
A COSY spectrum of the oligosaccharide
showing the proton assignments of the various residues and substituent
groups. F, FucNAc; p,
5N
OHC47NFmPse; S, Ser; X, Xyl;
B,
-hydroxybutyryl.

View larger version (49K):
[in a new window]
Fig. 5.
The top panel is a ROESY spectrum of the
anomeric region. The bottom panel is the TOCSY spectrum. The
connectivities between the various protons are as indicated in
the ROESY and TOCSY spectra. F, FucNAc; X, Xyl;
p, 5N
OHC47NFmPse; S, serine; and
HB,
-hydroxybutyryl. ROESY connectivities:
F1/S3, 4.54(FucNAc H1)
4.10 (Ser H3);
X1/F3, 4.43(Xyl H1)
3.84 (FucNAc H3).
NMR assignments
4.43) has a strong nuclear Overhauser effect interaction with the H3 of FucNAc (
3.82). H1 of FucNAc (
4.54) has a strong nuclear Overhauser effect interaction with the H3 proton of Ser (
4.10). Thus, the 5N
OHC47NFmPse residue must occupy a
terminal position in this molecule. These results indicate the
following structure:
-5N
OHC47NFmPse-(2
?)-
-Xyl-(1
3)-
-FucNAc-(1
3)-
-Ser. This sequence was confirmed by tandem MS/MS spectrometry, Fig. 6, because fragment ions due to the
successive losses of Ser (m/z 665.5), FucNAc-Ser
(m/z 478.5), and Xyl-FucNAc-Ser
(m/z 347.0) are observed. Methylation analysis
was required to determine the linkage position of the xylosyl residue.
Partially methylated alditol acetate derivatives were prepared and
analyzed by combined GC-MS. This analysis (results not shown) clearly
revealed the presence of a PMAA derived from a 4-linked xylosyl
pyranosyl residue or to a 5-linked xylosyl furanosyl residue
(m/z 118, 189). Because the NMR data clearly
showed that the Xyl was present as a
-xylopyranosyl residue, it is
concluded that this residue is 4-linked in the oligosaccharide.
Based on the above information, the structure of this molecule,
presented in Fig. 7, is as follows:
-5N
OHC47NFmPse-(2
4)-
-Xyl-(1
3)-
-FucNAc-(1
3)-
-Ser.

View larger version (10K):
[in a new window]
Fig. 6.
The tandem MS/MS spectrum of the
[M+H]+ 771.5 ion. This spectrum was obtained by
ESI-MS analysis. The fragmentation pattern is as indicated in the
figure.

View larger version (9K):
[in a new window]
Fig. 7.
The P. aeruginosa 1244 pilin glycan structure.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-carbon of a serine
residue. The calculated mass of the glycan, 666.5, corresponds to the
value by which pilin exceeds that predicted by the pilA
gene. This finding, as well as the absence of the nonmodified form of
this protein in cell extracts or glycosylation isoforms (5), shows that
each monomer is modified with a single glycan.
OHC47NfmPse has the same basic structure common to the
sialic acid family of sugars, which have been postulated to function as
biological masks protecting sensitive protein structures (43). The
presence of the pilin glycan may protect the pili from complement
binding and phagocytosis or protect potential epitopes from the host
B-cell response. The latter has been suggested as a role for
glycosylation of Campylobacter proteins (13) and the pili of
N. meningitidis (15). It is also possible that pilin glycosylation functions to protect the pilus against attack from proteolytic enzymes present as part of the host defense or as produced
by P. aeruginosa itself.
OHC47NfmPse would introduce a negative charge that
would lower the pilus isoelectric point, influence solubility, and
likely increase ionic interaction among pili and between the pili and extracellular structures. Because the total surface area of the pili is
a sizable fraction of the cell surface, it is clear that the pilin
glycan has the potential to be a major influence on the interaction of
the cell with its environment. This would include especially the
ability of P. aeruginosa to carry out
pilus-dependent functions such as twitching motility and
biofilm formation, processes that are important in pathogenesis
(46-49).
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
OHC47NFmPse, 5-N-
-hydroxybutyryl-7-N-formyl-pseudaminic
acid;
ROESY, rotating frame Overhauser effect NMR spectroscopy;
TOCSY, total correlated NMR spectroscopy;
Xyl, xylose.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Bodey, G. P.,
Bolivar, R.,
Fainstein, V.,
and Jadeja, L.
(1983)
Rev. Infect. Dis.
5,
279-313
2.
Hahn, H.
(1997)
Gene
192,
99-108
3.
Paranchych, W.,
and Frost, L. S.
(1988)
Adv. Microb. Physiol.
29,
53-114
4.
Strom, M. S.,
and Lory, S.
(1993)
Annu. Rev. Microbiol.
47,
565-596
5.
Castric, P.
(1995)
Microbiology
141,
1247-1254
6.
Lechner, J.,
and Wieland, F.
(1989)
Annu. Rev. Biochem.
58,
173-194
7.
Wieland, F.,
Heitzer, R.,
and Schaefer, W.
(1983)
Proc. Natl. Acad. Sci. U. S. A.
80,
5470-5474
8.
Wieland, F.,
Paul, G.,
and Sumper, M.
(1985)
J. Biol. Chem.
260,
15180-15185
9.
Erickson, P. R.,
and Herzberg, M. C.
(1993)
J. Biol. Chem.
268,
23780-23783
10.
Dobos, K. M.,
Swiderek, K.,
Khoo, K. H.,
Brennan, P. J.,
and Belisle, J. T.
(1995)
Infect. Immun.
63,
2846-2853
11.
Doig, P.,
Kinsella, N.,
Guerry, P.,
and Trust, T. J.
(1996)
Mol. Microbiol.
19,
379-387
12.
Logan, S. M.,
Trust, T. J.,
and Guerry, P.
(1989)
J. Bacteriol.
171,
3031-3038
13.
Szymanski, C. M.,
Yao, R.,
Ewing, C. P.,
Trust, T. J.,
and Guerry, P.
(1999)
Mol. Microbiol.
32,
1022-1030
14.
Brimer, C. D.,
and Montie, T. C.
(1998)
J. Bacteriol.
180,
3209-3217
15.
Parge, H. E.,
Forest, K. T.,
Hickey, M. J.,
Christensen, D. E.,
Getzoff, E. D.,
and Tainer, J. A.
(1995)
Nature
378,
32-38
16.
Stimson, E.,
Virji, M.,
Barker, S.,
Panico, M.,
Blench, I.,
Saunders, J.,
Payne, G.,
Moxon, E. R.,
Dell, A.,
and Morris, H. R.
(1996)
Biochem. J.
316,
29-33
17.
Stimson, E.,
Virji, M.,
Makepeace, K.,
Dell, A.,
Morris, H. R.,
Payne, G.,
Saunders, J. R.,
Jennings, M. P.,
Barker, S.,
Panico, M.,
Blench, I.,
and Moxon, E. R.
(1995)
Mol. Microbiol.
17,
1201-1214
18.
Knirel, Y. A.
(1990)
Crit. Rev. Microbiol.
17,
273-304
19.
Castric, P. A.,
Sidberry, H. F.,
and Sadoff, J. C.
(1989)
Mol. Gen. Genet.
216,
75-80
20.
Hitchcock, P. J.,
and Brown, T. M.
(1983)
J. Bacteriol.
154,
269-277
21.
McMichael, J. C.
(1992)
J. Gen. Microbiol.
138,
2687-2695
22.
Ramphal, R.,
Koo, L.,
Ishimoto, K. S.,
Totten, P. A.,
Lara, J. C.,
and Lory, S.
(1991)
Infect. Immun.
59,
1307-1311
23.
Castric, P. A.,
and Strobel, G. A.
(1969)
J. Biol. Chem.
244,
4089-4094
24.
Cassels, F. J.,
and London, J.
(1989)
J. Bacteriol.
171,
4019-4025
25.
Ghebregzabher, M.,
Rufini, S.,
Monaldi, B.,
and Lato, M.
(1976)
J. Chromatogr.
127,
133-162
26.
York, W. S.,
Darvill, A. G.,
McNeil, M.,
Stevenson, T. T.,
and Albersheim, P.
(1985)
Methods Enzymol.
118,
3-40
27.
Sadoff, J. C.,
Wright, D. C.,
Futrovsky, S.,
Sidberry, H.,
Collins, H.,
and Kaufmann, B.
(1985)
Antibiot. Chemother.
36,
134-146
28.
Cross, A. S.,
Opal, S. M.,
Palardy, J. E.,
Bodmer, M. W.,
and Sadoff, J. C.
(1993)
J. Infect. Dis.
167,
112-118
29.
Castric, P. A.,
and Deal, C. D.
(1994)
Infect. Immun.
62,
371-376
30.
Liu, P. V.,
Matsumoto, H.,
Kusama, H.,
and Bergan, T.
(1983)
Int. J. Syst. Bacteriol.
33,
256-264
31.
Bradley, D. E.
(1980)
Can. J. Microbiol.
26,
146-154
32.
Lanyi, B.,
and Bergan, T.
(1978)
in
Methods in Microbiology
(Bergan, T.
, and Norris, J. R., eds), Vol. 10
, pp. 93-168, Academic Press, London
33.
Knirel, Y. A.,
Kocharova, N. A.,
Shashkov, A. S.,
Dmitriev, B. A.,
Kochetkov, N. K.,
Stanislavsky, E. S.,
and Mashilova, G. M.
(1987)
Eur. J. Biochem.
163,
639-652
34.
Angyal, S. J.
(1979)
Carbohydr. Res.
77,
37-50
35.
Raetz, C. R.
(1990)
Annu. Rev. Biochem.
59,
129-170
36.
Burda, P.,
and Aebi, M.
(1999)
Biochim. Biophys. Acta
1426,
239-257
37.
Bock, K.,
Schuster-Kolbe, J.,
Altman, E.,
Allmaier, G.,
Stahl, B.,
Christian, R.,
Sleytr, U. B.,
and Messner, P.
(1994)
J. Biol. Chem.
269,
7137-7144
38.
Paranchych, W.,
Sastry, P. A.,
Frost, L. S.,
Carpenter, M.,
Armstrong, G. D.,
and Watts, T. H.
(1979)
Can. J. Microbiol.
25,
1175-1181
39.
Frost, L. S.,
and Paranchych, W.
(1977)
J. Bacteriol.
131,
259-269
40.
Virji, M.,
Saunders, J. R.,
Sims, G.,
Makepeace, K.,
Maskell, D.,
and Ferguson, D. J. P.
(1993)
Mol. Microbiol.
10,
1013-1028
41.
Marceau, M.,
Forest, K.,
Beretti, J. L.,
Tainer, J.,
and Nassif, X.
(1998)
Mol. Microbiol.
27,
705-715
42.
Hamadeh, R. M.,
Estabrook, M. M.,
Zhou, P.,
Jarvis, G. A.,
and Griffiss, J. M.
(1995)
Infect. Immun.
63,
4900-4906
43.
Schauer, R.
(1985)
Trends Biochem. Sci.
10,
357-360
44.
Lee, K. K.,
Sheth, H. B.,
Wong, W. Y.,
Sherburne, R.,
Paranchych, W.,
Hodges, R. S.,
Lingwood, C. A.,
Krivan, H.,
and Irvin, R. T.
(1994)
Mol. Microbiol.
11,
705-713
45.
Irvin, R. T.
(1990)
in
Microbial Cell Surface Hydrophobicity
(Doyle, R. J.
, and Rosenberg, M., eds)
, pp. 137-177, American Society for Microbiology, Washington, D. C.
46.
O'Toole, G. A.,
and Kolter, R.
(1998)
Mol. Microbiol.
30,
295-304
47.
Kang, P. J.,
Hauser, A. R.,
Apodaca, G.,
Fleiszig, S. M. J.,
Wiener-Kronish, J.,
Mostov, K.,
and Engel, J. N.
(1997)
Mol. Microbiol.
24,
1249-1262
48.
Davey, M. E.,
and O'Toole, G. A.
(2000)
Microbiol. Mol. Biol. Rev.
64,
847-867
49.
Comolli, J. C.,
Hauser, A. R.,
Waite, L.,
Whitchurch, C. B.,
Mattick, J. S.,
and Engel, J. N.
(1999)
Infect. Immun.
67,
3625-3630
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Bosch, A. Minan, C. Vescina, J. Degrossi, B. Gatti, P. Montanaro, M. Messina, M. Franco, C. Vay, J. Schmitt, et al. Fourier Transform Infrared Spectroscopy for Rapid Identification of Nonfermenting Gram-Negative Bacteria Isolated from Sputum Samples from Cystic Fibrosis Patients J. Clin. Microbiol., August 1, 2008; 46(8): 2535 - 2546. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. VanDyke, J. Wu, S. Y. M. Ng, M. Kanbe, B. Chaban, S.-I. Aizawa, and K. F. Jarrell Identification of a Putative Acetyltransferase Gene, MMP0350, Which Affects Proper Assembly of both Flagella and Pili in the Archaeon Methanococcus maripaludis J. Bacteriol., August 1, 2008; 190(15): 5300 - 5307. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Horzempa, T. K. Held, A. S. Cross, D. Furst, M. Qutyan, A. N. Neely, and P. Castric Immunization with a Pseudomonas aeruginosa 1244 Pilin Provides O-Antigen-Specific Protection Clin. Vaccine Immunol., April 1, 2008; 15(4): 590 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Taguchi, S. Shibata, T. Suzuki, Y. Ogawa, S.-I. Aizawa, K. Takeuchi, and Y. Ichinose Effects of Glycosylation on Swimming Ability and Flagellar Polymorphic Transformation in Pseudomonas syringae pv. tabaci 6605 J. Bacteriol., January 15, 2008; 190(2): 764 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Faridmoayer, M. A. Fentabil, D. C. Mills, J. S. Klassen, and M. F. Feldman Functional Characterization of Bacterial Oligosaccharyltransferases Involved in O-Linked Protein Glycosylation J. Bacteriol., November 15, 2007; 189(22): 8088 - 8098. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Voisin, J. V. Kus, S. Houliston, F. St-Michael, D. Watson, D. G. Cvitkovitch, J. Kelly, J.-R. Brisson, and L. L. Burrows Glycosylation of Pseudomonas aeruginosa Strain Pa5196 Type IV Pilins with Mycobacterium-Like {alpha}-1,5-Linked D-Araf Oligosaccharides J. Bacteriol., January 1, 2007; 189(1): 151 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. Knirel, O. V. Bystrova, N. A. Kocharova, U. Zahringer, and G. B. Pier Review: Conserved and variable structural features in the lipopolysaccharide of Pseudomonas aeruginosa Innate Immunity, December 1, 2006; 12(6): 324 - 336. [Abstract] [PDF] |
||||
![]() |
A. J.-L. Le Quere, W. J. Deakin, C. Schmeisser, R. W. Carlson, W. R. Streit, W. J. Broughton, and L. S. Forsberg Structural Characterization of a K-antigen Capsular Polysaccharide Essential for Normal Symbiotic Infection in Rhizobium sp. NGR234: DELETION OF THE rkpMNO LOCUS PREVENTS SYNTHESIS OF 5,7-DIACETAMIDO-3,5,7,9-TETRADEOXY-NON-2-ULOSONIC ACID J. Biol. Chem., September 29, 2006; 281(39): 28981 - 28992. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. C. Schoenhofen, D. |